Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  3. Research Domains
  5. Engineering
  7. Environmental Engineering
  9. Air Pollution Modelling And Control
  11. Development And Validation Of A Stability-indicating Rp-hplc Method For Edaravone Quantification

Development and Validation of a Stability-Indicating RP-HPLC Method for Edaravone Quantification

Riuna O'Neill1, Okhee Yoo1,2,3,4, Philip Burcham1,5

  • 1Division of Pharmacy, School of Allied Health, University of Western Australia, Perth, WA 6009, Australia.

Molecules (Basel, Switzerland)
|July 12, 2025

Related Experiment Videos

Detection of Regulated Ergot Alkaloids in Food Matrices by Liquid Chromatography-Trapped Ion Mobility Spectrometry-Time-of-Flight Mass Spectrometry
08:56

Detection of Regulated Ergot Alkaloids in Food Matrices by Liquid Chromatography-Trapped Ion Mobility Spectrometry-Time-of-Flight Mass Spectrometry

Published on: November 22, 2024

784
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.2K
Automated 90Sr Separation and Preconcentration in a Lab-on-Valve System at Ppq Level
08:53

Automated 90Sr Separation and Preconcentration in a Lab-on-Valve System at Ppq Level

Published on: June 6, 2018

8.1K

View abstract on PubMed

Summary
This summary is machine-generated.

A new stability-indicating assay using reversed-phase high-performance liquid chromatography (RP-HPLC) accurately quantifies edaravone. This method is crucial for developing new formulations of the motor neurone disease (MND) treatment.

Area of Science:

  • Pharmaceutical Sciences
  • Analytical Chemistry
  • Neuroscience

Background:

  • Edaravone is a critical treatment for motor neurone disease (MND), available as IV infusion and oral suspension.
  • Developing novel edaravone formulations necessitates a validated stability-indicating assay for accurate quantification.
  • Existing analytical methods may not fully meet the requirements for new drug development.

Purpose of the Study:

  • To develop and validate a stability-indicating reversed-phase high-performance liquid chromatography (RP-HPLC) method for edaravone.
  • To ensure the method provides specific, precise, and accurate quantification of edaravone content.
  • To support the development of new edaravone formulations.

Main Methods:

  • Evaluation of ten RP-HPLC methods based on published literature.
Keywords:
HPLCassayedaravonemotor neurone disease

Related Experiment Videos

Detection of Regulated Ergot Alkaloids in Food Matrices by Liquid Chromatography-Trapped Ion Mobility Spectrometry-Time-of-Flight Mass Spectrometry
08:56

Detection of Regulated Ergot Alkaloids in Food Matrices by Liquid Chromatography-Trapped Ion Mobility Spectrometry-Time-of-Flight Mass Spectrometry

Published on: November 22, 2024

784
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.2K
Automated 90Sr Separation and Preconcentration in a Lab-on-Valve System at Ppq Level
08:53

Automated 90Sr Separation and Preconcentration in a Lab-on-Valve System at Ppq Level

Published on: June 6, 2018

8.1K
  • Optimization of chromatographic conditions using a gradient method on an Agilent ZORBAX Extend-C18 column.
  • Validation of the method according to ICH Q2(R2) guidelines for specificity, linearity, sensitivity, accuracy, and precision.

    • Main Results:

    • A robust RP-HPLC method was developed, achieving excellent separation of edaravone from impurities and degradants.
    • The method demonstrated high precision and accuracy within the concentration range of 6.8-68.6 µg/mL.
    • The assay was recommended for use without methyl hydroxybenzoate (MHB) as an internal standard.

    Conclusions:

    • The developed stability-indicating RP-HPLC method is suitable for quantifying edaravone in various formulations.
    • This validated assay is essential for quality control and stability testing during the development of novel edaravone products.
    • The method's specificity and accuracy support ongoing research into improved edaravone treatments for MND.
    stability